Short answer · Medically reviewed summary · Last updated: 2026-05-08
Hallucinogen Persistent Perception Disorder (HPPD) was first formally identified in the 1950s and 60s, though it was long dismissed as mere "flashbacks" or psychological trauma. Today, medical science recognizes Hallucinogen Persistent Perception Disorder as a distinct, chronic neurological condition characterized by persistent visual disturbances that endure long after the initial substance has left the body. When was Hallucinogen Persistent Perception Disorder first described? The clinical history of Hallucinogen Persistent Perception Disorder began in the 1950s following the introduction of LSD into psychiatric research.
2 people with Hallucinogen Persistent Perception Disorder have shared their first-person experience on this question at DiseaseMaps.
What is the history of Hallucinogen Persistent Perception Disorder?
History of Hallucinogen Persistent Perception Disorder: when and how it was discovered, and the milestones in research since, medically reviewed.
Hallucinogen Persistent Perception Disorder (HPPD) was first formally identified in the 1950s and 60s, though it was long dismissed as mere "flashbacks" or psychological trauma. Today, medical science recognizes Hallucinogen Persistent Perception Disorder as a distinct, chronic neurological condition characterized by persistent visual disturbances that endure long after the initial substance has left the body.
When was Hallucinogen Persistent Perception Disorder first described?
The clinical history of Hallucinogen Persistent Perception Disorder began in the 1950s following the introduction of LSD into psychiatric research. Early observers often referred to these phenomena as "flashbacks," a term that erroneously suggested the patient was re-experiencing the drug's psychological effects. It was not until the 1980s, particularly through the work of researchers like Dr. Henry Abraham, that the condition was defined as a sensory, rather than purely psychological, disorder. His seminal studies helped distinguish Hallucinogen Persistent Perception Disorder from transient post-drug effects, emphasizing the chronic, organic nature of the visual disturbances.
How has our understanding of the condition evolved?
Historically, the medical community struggled to differentiate between psychological anxiety and the genuine sensory processing errors found in Hallucinogen Persistent Perception Disorder. Misconceptions once led clinicians to categorize these patients under personality disorders or schizophrenia. Modern neuroimaging and clinical research have corrected this, showing that Hallucinogen Persistent Perception Disorder involves altered neuroplasticity and hyperexcitability within the visual cortex.
What are the major milestones in treatment and advocacy?
While no FDA-approved cure exists, the evolution of treatment has been marked by trial and error. Key historical milestones include:
- The 1980s: The transition from treating the condition as "psychological" to "neurological."
- The 1990s-2000s: The exploration of anticonvulsants and benzodiazepines as primary management tools.
- Current era: The realization that certain antipsychotics and SSRIs may actually exacerbate the visual symptoms of Hallucinogen Persistent Perception Disorder.
Next steps
- Consult a neurologist or psychiatrist specializing in neuro-ophthalmology to discuss your specific visual symptoms.
- Join the community of 260 people at DiseaseMaps.org to share experiences and coping strategies for living with Hallucinogen Persistent Perception Disorder.
- Maintain a detailed symptom log to identify potential triggers or substances that worsen your visual disturbances.
Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Abraham, H. D. (1983). Visual phenomenology of the LSD flashback. Archives of General Psychiatry.
- Orphanet: Portal for rare diseases and orphan drugs.
- PubMed Central: Current literature on the neurobiology of hallucinogen-induced persistent perceptual changes.
It has started to be known as "HPPD" since the late 90's to early 2000's.
No one has really "discovered" HPPD, it has been named that way after many reports of people having permanent visuals after taking certain drugs.
Posted Jun 11, 2018 by dayum_som 4020
In 1986 the publication of DSM-III-R by the American Psychiatric Association acknowledged flashbacks as a diagnosis under 'post hallucinogen perception disorder'. These disorders were reviewed and refined in the DSM-IV as 'Hallucinogen Persisting Perception Disorder".
Posted Feb 17, 2019 by Nicolas 4550
